Tagged Articles

Auxilium Pharmaceuticals 39 articles

Major League Baseball players suspended for testosterone drug use

“… as long as men and women play sports, they will look for whatever edge is available to them. Some legal. Some not so legal,” says ESPN writer Jason Stark about the use of synthetic testosterone to boost performance in professional sports. In August, San Francisco Giants left field Melky Cabrera and Oakland Athletics pitcher Bartolo Colon were suspended after testing positive for synthetic testosterone, which can mimic anabolic steroids if used in sufficient quantities. The suspensions prompted at least one Major League Baseball insider to warn of an epidemic of the performance enhancing drugs within the sport. Of course, ... Read More

UFC President voices approval for testosterone replacement therapy

Ultimate Fighting Championship (UFC) President Dana White told Fox Sports that testosterone replacement therapy (TRT) is “great” because it can help restore hormone levels in aging men. “Here’s the thing about TRT: It’s absolutely 100 percent legal,” Mr. White told Fox Sports. He explained, “As sports medicine continues to advance, this is one of those things where every guy’s testosterone level starts to drop as they get older and this is basically sports science now where they can bring it back up to a normal level. And I think it’s great, it’s absolutely fair, it’s legal. “The problem is, there ... Read More

Study finds many men can restore testosterone levels with diet and exercise

Doctors should encourage overweight, middle-aged, and pre-diabetic men to lose weight through diet and exercise before putting them on testosterone replacement therapy, says the author of a new study presented at the a Houston medical conference. Dr. Frances Hayes, a professor at St. Vincent’s University Hospital in Dublin, Ireland, said that men who suffer from low testosterone levels can restore their hormones by nearly 50 percent by adhering to a healthier, more active lifestyle. The study monitored 900 American men with an average age of 54 who had been diagnosed with impaired glucose tolerance, or pre-diabetes. The men, all of ... Read More

Improper exposure to, use of Testosterone drugs can be harmful

The sharp upswing in sales of Androgel,Testim and other hormone-replacement drugs in recent years indicates record numbers of American men are seeking a boost in their testosterone levels. But while men who use these drugs may experience some relief from age-related declines in strength and libido, among other benefits, the drugs may also work behind the scenes to create a number of harmful side effects that may not be so easily or readily noticeable at first. Some of the most commonly reported side effects of topical testosterone drugs, which are usually applied to the shoulders, upper arms, or abdomen, are ... Read More

Study blames surge in testosterone drug sales on “disease mongering” marketing

Testosterone replacement drugs are surging in popularity in Australia and Canada, thanks to slick promotional campaigns and “disease mongering” by pharmaceutical companies, said the author of a new study published in the Medical Journal of Australia (MJA). In the study, David Handelsman, director of the ANZAC Research Institute at the University of Sydney, examined patterns in testosterone drug prescribing in Australia from 1992 to 2010. He found total expenditures on testosterone prescriptions more than doubled in that time period after taking into account inflation and population growth, yet there was no correlating increase in the number of approved uses for ... Read More

Testim maker poised to expand its share of men’s health market

Bolstered by soaring demand for testosterone replacement products, a deal with GlaxoSmithKline to market its top drug Testim, and now favorable results of a new drug study to treat penile curvature, things are looking up for Auxilium Pharmaceuticals. Reuters reports that shares of Auxilium, a small drug company based in Malvern, Pennsylvania, shot up 17 percent Monday on news that two late-stage trials indicated its drug Xiaflex reduced curvature of the penis by more than 30 percent in men with Peyronie’s Disease, a condition caused when excessive collagen protein deposits create curvature and sometimes painful erections. Xiaflex is already approved ... Read More

Testim maker files patent infringement lawsuit

Auxilium Pharmaceuticals, the maker of Testim® 1%, has filed a lawsuit against Watson Laboratories Inc. and related companies for allegedly violating patents protecting its best-selling testosterone replacement gel. Auxilium and FCB I LLC, a subsidiary of Xstelos Holdings Inc., filed the lawsuit in U.S. District Court for the District of New Jersey on May 23, accusing Watson Laboratories, Watson Pharmaceuticals, Inc. and Watson Pharma Inc. of infringing on 10 Testim® patents listed in the U.S. Food and Drug Administration’s Approved Drug Products with Therapeutic Equivalence Evaluations, better known in the industry as the FDA’s “Orange Book.” According to Auxilium, the ... Read More

Testosterone wars heat up as Testim maker allies with GlaxoSmithKline

Testim manufacturer Auxilium Pharmaceuticals Inc. of Malvern, Pennsylvania, has entered a partnership with GlaxoSmithKline to drive up sales of the testosterone drug, the companies announced this week. Testim is a topical gel containing one percent testosterone, prescribed as a hormone-replacement therapy for men with clinically low testosterone levels and the physical slow-down that generally accompanies “low T,” as the condition is sometimes called. Testim and other testosterone replacement therapies are also sought after by men who take the drug for recreational purposes. The effects of excessive testosterone in men are virtually the same as taking steroids, with increased muscle mass ... Read More

Drugmakers credit Androgel and Testim for first-quarter profit surge

The market for testosterone replacement drugs is booming, with no signs of easing in the future, market analysts say. Abbott Laboratories, the maker of Androgel 1.62% and Androgel 1% and Auxilium Pharmaceuticals, which makes Testim 1%, are aggressively marketing their testosterone drugs to millions of men in the U.S. with low testosterone levels, and those efforts are paying off. Sales of testosterone replacement drugs hit $1.6 billion in 2011, up 133 percent in just four years. According to data compiled by Bloomberg analysts, 5.6 million prescriptions were written for testosterone replacement therapies last year and sales are expected to triple ... Read More